Formulations for parenteral use of estramustine phosphate and amino acids
CA 2384726 A1 · Owner: Buzzi, Giovanni · Inventors: Muggetti, Lorena; Colombo, Paolo; Buzzi, Giovanni
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A pharmaceutical formulations which comprises a parenterally acceptable carrier or diluent and estramustine phosphate and a basic amino acid. The formulation can be administered according to a combined chemotherapy regimen in association with one or more chemotherapeutic agents. The formulation also enables the estramustine phosphate to be administered with no side effects at the site of injection.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 13, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 13, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 13, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.